Hopes dashed as last HIV vaccine trial in Africa for this decade ends in failure

Trial ‘PrEPVacc’ was testing two different vaccine regimens on about 1,500 volunteers in Uganda, Tanzania and South Africa

ICMR, central drug regulator admit COVID-19 vaccine side effects; health ministry rubbishes claim

Government called revelations ‘ill-informed & erroneous’

The 'vaccinegate' of Italy

A study in Italy has found major contaminants in vaccines that are used the world over

COVID-19 vaccine development: It’s a relay race

The reason trials are taking shorter time is because developers are taking more risks

GlaxoSmithKline fined for unethical drug trials on infants in Argentina

Pharmaceutical giant to file appeal in apex court

Drugs standard body proposes banning animal test for human vaccines

The proposal has been put in public domain for comments    

World AIDS Day: Battles won and lost hold valuable lessons for managing COVID-19

Resources have helped reduce morbidity and mortality in low- and middle-income regions. AIDS-related deaths have declined worldwide by 39% since …

We’re entering a new phase of COVID, where we each have to assess and mitigate our own risk. But how?

COVID vaccines aren’t perfect and don’t completely stop transmission, but they greatly reduce your likelihood of becoming …

Pfizer’s COVID-19 vaccine becomes first to get emergency authorisation

UK government gives nod on basis of interim results, vaccine to be made available by next week  

How do you make a universal flu vaccine? A microbiologist explains

Success of mRNA vaccines for COVID-19 shows promise for their use in achieving the vision of an effective universal influenza vaccine

COVID-19 vaccines: How Pfizer and Moderna’s 95% effective mRNA shots work

Should we expect the pandemic to be over once a vaccine is available for public use? Not exactly. A vaccine will not be perfect, and it takes …

The ‘kraken’ COVID variant XBB.1.5 is rising quickly in the US — here’s what it could mean for the UK

While XBB’s mutations enable it to evade our immune systems better than previous omicron subvariants, it doesn’t appear to be causing&…

COVID-19 immunity: how long does it last?

In UK’s second wave, previously infected health workers were either completely protected from reinfection or were asymptomatic 

India should not prefer Russian COVID-19 vaccine over own: Vaccinologist Peter Hotez

India has a golden chance to emerge as a superpower; vaccine dissemination would be a paramount challenge, Hotez says in an …

Vaccine hope

While Africa gets its first vaccine to fight malaria, India is still in the early stages of clinical trials

COVID-19: Extensive research underway; how much will it help?

As many as 42 vaccines were in preclinical stage and two vaccines in Phase I clinical trials as of March 20, according to WHO  

Phase 1 human trials of Oxford University encouraging: Lancet

The sample size will have to be expanded across demography to check safety and efficacy  

How ‘good’ does a COVID-19 vaccine need to be? A new study has answers

A vaccine with an efficacy as low as 60% could still stop the pandemic. However, most, if not all of the population, would have to be vaccinated

How ‘vaccine nationalism’ could block vulnerable populations’ access to COVID-19 vaccines

Vaccine nationalism also runs against the fundamental principles of vaccine development and global public health

Vaccine hesitancy on the rise across the globe, reveals cross-country survey

India bucks the trend; Afghanistan, Indonesia, Pakistan, the Philippines, South Korea major concerns

Harmful Vaccines

Public Health Activist Anand Rai explains how harmful chemicals are being used in children's vaccines. ENGLISH TRANSLATION I got to know …